Author:
Bai Xiao,Qi Zaiwen,Zhu Mingzhen,Lu Zhuangzhuang,Zhao Xin,Zhang Lining,Song Guangmin
Abstract
Abstract
Background
The mesenchymal stem cells (MSCs) were used to repair tissue injury. However, the treatment effect was not satisfactory. We investigated whether lncRNA MIR155HG could promote survival and migration of MSCs under oxidative stress, which mimics in vivo environments. Furthermore, we studied the protective effect of exosomes secreted by MSCs transfected with MIR155HG on endothelial cells. This study aimed to determine whether exploiting MSCs and exosomes modified with lncRNA MIR155HG would exert synergistic therapeutic effect to attenuate vein graft intimal hyperplasia more effectively.
Methods
Lentivirus containing lncRNA MIR155HG overexpressing vector was packaged and used to infect MSCs. Then, CCK-8 assay, flow cytometry, Transwell assay, and Elisa assay were used to assess the functional changes of MSCs with overexpressed MIR155HG (OE-MSCs). Furthermore, the associated pathways were screened by Western blot. MIR155HG-MSCs-derived exosomes (OE-exo) were collected and co-cultured with human umbilicus vein endothelial cell (HUVEC). We validated the protective effect of OE-exo on HUVEC. In vivo, both MSCs and exosomes modified with MIR155HG were injected into a vein graft rat model via tail vein. We observed MSCs homing and intimal hyperplasia of vein graft using a fluorescent microscope and histological stain.
Results
Our study found that lncRNA MIR155HG promoted proliferation, migration, and anti-apoptosis of MSCs. NF-κB pathway took part in the regulation process induced by MIR155HG. OE-exo could enhance the activity and healing ability of HUVEC and reduce apoptosis. In vivo, OE-MSCs had a higher rate of homing to vascular endothelium. The combined treatment with OE-MSCs and OE-exo protected vascular endothelial integrity, reduced inflammatory cell proliferation, and significantly attenuated intimal hyperplasia of vein graft.
Conclusion
LncRNA MIR155HG could promote the survival and activity of MSCs, and reduce the apoptosis of HUVECs using exosome delivery. Exploiting MSCs and exosomes modified with MIR155HG could attenuate vein graft intimal hyperplasia more effectively and maximize the surgical effect.
Funder
National Natural Science Foundation of China
Key Technology Research and Development Program of Shandong
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Medicine,Medicine (miscellaneous)
Reference36 articles.
1. Wu BJ, Li Y, Ong KL, Sun Y, Johns D, Barter PJ, Rye KA. The cholesteryl ester transfer protein inhibitor, des-fluoro-anacetrapib, prevents vein bypass-induced neointimal hyperplasia in New Zealand white rabbits. Sci Rep. 2019;9(1):16183–91.
2. Tianshu C, Congrong G, Zhiwei Z, Fei L, Ayu S, Yuanbiao Z, Jing C, Ge J. Rapamycin combined with α-cyanoacrylate contributes to inhibiting intimal hyperplasia in rat models. Arq Bras Cardiol. 2019;112(1):3–10.
3. Dai C, Zhou Y, Zhang B, Ge J. Bletilla striata polysaccharide prevents restenosis of vein graft through inhibiting cell proliferation in rat model. Cell Transplant. 2020;29(11):1–11.
4. Baganha F, de Jong A, Jukema JW, Quax PHA, de Vries MR. The role of immunomodulation in vein graft remodeling and failure. J Cardiovasc Transl Res. 2021;14(1):100–9.
5. Liu Z, Wu C, Zou X, Shen W, Yang J, Zhang X, Hu X, Wang H, Liao Y, Jing T. Exosomes derived from mesenchymal stem cells inhibit neointimal hyperplasia by activating the Erk1/2 signalling pathway in rats. Stem Cell Res Ther. 2020;11(1):220–33.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献